ACTRN12606000520538已完成1 期
Phase I accelerated dose-escalation study to determine the safety and tolerability of CYT997 when given as an oral capsule every two weeks in patients with advanced solid tumours
Cytopia Research Pty Ltd0 个研究点目标入组 15 人开始时间: 2006年12月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 ot stated（—）
- 性别
- All
入选标准
- •(i) Confirmed solid malignancy; (ii) Life-expectancy of greater than 3 months; (iii) No anticancer chemotherapy or hormonal therapy for the preceding 4 weeks; (iv) Adequate organ and marrow function.
排除标准
- •(i) Patients must not have received other experimental agents in preceding 4 weeks; (ii) Known brain metastases; (iii) Patients with various cardiovascular risk factors are excluded; (iv) Pregnancy and immune deficiency.
研究者
相似试验
终止
1 期
Training Intensity Early after StrokeStroke - IschaemicStrokeACTRN12619001423101The Florey Institute of Neuroscience and Mental Health26
招募中
1 期
A phase 1 dose escalating study of ATX-101 given by intravenous infusion once every week in patients with advanced solid tumours.ACTRN12618001070224Therapim Pty Ltd36
进行中（未招募）
1 期
Phase I trial of afatinib in pediatric tumoursPaediatric patients with recurrent//refractory high grade glioma (HGG), diffuse intrinsic pontine glioma (DIPG), low grade astrocytoma, neuroblastoma, ependymoma, medulloblastoma/primitive neuroectodermal tumours (PNET), rhabdomyosarcoma (RMS) and/or other solid tumours with known ErbB pathway deregulation regardless of tumour histologyMedDRA version: 18.0Level: LLTClassification code 10029091Term: Neoplasm of unspecified nature of endocrine glands and other parts of nervous systemSystem Organ Class: 100000004864MedDRA version: 18.0Level: LLTClassification code 10029006Term: Neoplasm of uncertain behavior of brain and spinal cordSystem Organ Class: 100000004864MedDRA version: 18.0Level: LLTClassification code 10029050Term: Neoplasm of uncertain behaviour of connective and other soft tissueSystem Organ Class: 100000004864MedDRA version: 18.0Level: LLTClassification code 10028992Term: Neoplasm CNSSystem Organ Class: 100000004864EUCTR2014-002123-10-ESBoehringer Ingelheim España, S.A.563
进行中（未招募）
1 期
Phase I trial of afatinib in pediatric tumoursEUCTR2014-002123-10-ITBoehringer Ingelheim Italia S.p.A.60
进行中（未招募）
1 期
Phase I trial of afatinib in pediatric tumoursEUCTR2014-002123-10-FRBoehringer Ingelheim France563